The WWRD Study: AVM0703 for Treatment of Leukemia or Lymphoma
Condition: Lymphoid Malignancies Intervention: Drug: Supra-Pharmacologic Dexamethasone sodium phosphate Sponsors: AVM Biotechnology LLC; Medpace, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Biotechnology | Cancer & Oncology | Dexamethasone | Leukemia | Lymphoma | Research | Sodium | Study